160 related articles for article (PubMed ID: 19771324)
1. Molecule of the Month. Denosumab.
Drug News Perspect; 2009; 22(6):356. PubMed ID: 19771324
[No Abstract] [Full Text] [Related]
2. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.
Eastell R; Christiansen C; Grauer A; Kutilek S; Libanati C; McClung MR; Reid IR; Resch H; Siris E; Uebelhart D; Wang A; Weryha G; Cummings SR
J Bone Miner Res; 2011 Mar; 26(3):530-7. PubMed ID: 20839290
[TBL] [Abstract][Full Text] [Related]
3. Denosumab for treatment of postmenopausal osteoporosis.
Chitre M; Shechter D; Grauer A
Am J Health Syst Pharm; 2011 Aug; 68(15):1409-18. PubMed ID: 21785030
[TBL] [Abstract][Full Text] [Related]
4. Denosumab.
Rizzoli R; Yasothan U; Kirkpatrick P
Nat Rev Drug Discov; 2010 Aug; 9(8):591-2. PubMed ID: 20671758
[No Abstract] [Full Text] [Related]
5. Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
Cummings SR; San Martin J; McClung MR; Siris ES; Eastell R; Reid IR; Delmas P; Zoog HB; Austin M; Wang A; Kutilek S; Adami S; Zanchetta J; Libanati C; Siddhanti S; Christiansen C;
N Engl J Med; 2009 Aug; 361(8):756-65. PubMed ID: 19671655
[TBL] [Abstract][Full Text] [Related]
6. Osteoporosis drug licensed for women with high fracture risk.
Traynor K
Am J Health Syst Pharm; 2010 Jul; 67(13):1046. PubMed ID: 20554585
[No Abstract] [Full Text] [Related]
7. Denosumab update.
Lewiecki EM
Curr Opin Rheumatol; 2009 Jul; 21(4):369-73. PubMed ID: 19424068
[TBL] [Abstract][Full Text] [Related]
8. [Denosumab. The first inhibitor of RANK-ligand for treatment of osteoporosis].
Bruhn C
Med Monatsschr Pharm; 2010 Oct; 33(10):370-5. PubMed ID: 21072910
[TBL] [Abstract][Full Text] [Related]
9. Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass.
Bone HG; Bolognese MA; Yuen CK; Kendler DL; Miller PD; Yang YC; Grazette L; San Martin J; Gallagher JC
J Clin Endocrinol Metab; 2011 Apr; 96(4):972-80. PubMed ID: 21289258
[TBL] [Abstract][Full Text] [Related]
10. Increasing options for the treatment of osteoporosis.
Khosla S
N Engl J Med; 2009 Aug; 361(8):818-20. PubMed ID: 19671654
[No Abstract] [Full Text] [Related]
11. Denosumab--a new option in the treatment of osteoporosis.
Franek E
Endokrynol Pol; 2011; 62(1):79-83. PubMed ID: 21365584
[TBL] [Abstract][Full Text] [Related]
12. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
Wensel TM; Iranikhah MM; Wilborn TW
Pharmacotherapy; 2011 May; 31(5):510-23. PubMed ID: 21923432
[TBL] [Abstract][Full Text] [Related]
13. Denosumab for the treatment of postmenopausal osteoporosis.
Lewiecki EM
Womens Health (Lond); 2009 Jan; 5(1):15-22. PubMed ID: 19274891
[No Abstract] [Full Text] [Related]
14. Denosumab: new horizons in the treatment of osteoporosis.
Wilton JM
Nurs Womens Health; 2011; 15(3):249-52. PubMed ID: 21672176
[No Abstract] [Full Text] [Related]
15. Denosumab and bisphosphonates: different mechanisms of action and effects.
Baron R; Ferrari S; Russell RG
Bone; 2011 Apr; 48(4):677-92. PubMed ID: 21145999
[TBL] [Abstract][Full Text] [Related]
16. Effect of RANKL-specific denosumab on osteoclast number and function: a potential friend or foe?
Tankó LB
Curr Opin Investig Drugs; 2007 Oct; 8(10):830-5. PubMed ID: 17907059
[TBL] [Abstract][Full Text] [Related]
17. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
Bone HG; Bolognese MA; Yuen CK; Kendler DL; Wang H; Liu Y; San Martin J
J Clin Endocrinol Metab; 2008 Jun; 93(6):2149-57. PubMed ID: 18381571
[TBL] [Abstract][Full Text] [Related]
18. A step in the journey of denosumab from bone-targeted therapy to seed- and soil-targeted therapy.
Vignot S; Khayat D
J Clin Oncol; 2009 Apr; 27(10):1534-6. PubMed ID: 19237628
[No Abstract] [Full Text] [Related]
19. Denosumab.
Dubois EA; Rissmann R; Cohen AF
Br J Clin Pharmacol; 2011 Jun; 71(6):804-6. PubMed ID: 21434974
[No Abstract] [Full Text] [Related]
20. Denosumab for the treatment of osteoporosis.
Iqbal J; Sun L; Zaidi M
Curr Osteoporos Rep; 2010 Dec; 8(4):163-7. PubMed ID: 20857349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
